Helen Stephens Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$455K Buy
379
+25
+7% +$25.5K 0.08% 93
2026
Q1
$326K Buy
354
+40
+13% +$40.6K 0.07% 91
2025
Q4
$338K Hold
314
0.07% 87
2025
Q3
$240K Hold
314
0.05% 101
2025
Q2
$245K Hold
314
0.06% 79
2025
Q1
$259K Hold
314
0.07% 72
2024
Q4
$242K Sell
314
-76
-19% -$62.9K 0.07% 78
2024
Q3
$346K Buy
390
+5
+1% +$4.5K 0.1% 65
2024
Q2
$349K Buy
385
+1
+0.3% +$800 0.12% 62
2024
Q1
$299K Buy
384
+13
+4% +$9.25K 0.12% 57
2023
Q4
$216K Buy
+371
New +$217K 0.1% 72

Other funds holding LLY

Helen Stephens Group's LLY Position: Q2 2026 in Review

Helen Stephens Group increased its Eli Lilly (LLY) stake by 7.1% in Q2 2026, buying an estimated $25.5K and bringing the position to 379 shares worth $455K. The position accounts for 0.08% of the portfolio, ranked #93.

Helen Stephens Group first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Helen Stephens Group held 379 shares of Eli Lilly worth $455K as of Q2 2026.
  • Helen Stephens Group bought 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
  • Eli Lilly made up 0.08% of Helen Stephens Group's portfolio in Q2 2026, its #93 holding.
  • Helen Stephens Group first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Helen Stephens Group's 13F filing for Q2 2026, filed 31 Jul 2026.